|
|
||||||||
Vol. 83, Issue 6, 1842-1848, December 1997
Biophysics Group, Research Institute for Electronic Science, Hokkaido University, Sapporo 060, Japan
Hoshi, Yoko, Osamu Hazeki, Yasuyuki Kakihana, and Mamoru
Tamura. Redox behavior of cytochrome oxidase in the rat brain measured by near-infrared spectroscopy. J. Appl.
Physiol. 83(6): 1842-1848, 1997.
Using
near-infrared spectroscopy, we developed a new approach for measuring
the redox state of cytochrome oxidase in the brain under normal
blood-circulation conditions. Our algorithm does not require the
absorption coefficient of cytochrome oxidase, which differs from study
to study. We employed this method for evaluation of effects of changes
in oxygen delivery on cerebral oxygenation in rats. When fractional
inspired oxygen was decreased in a stepwise manner from
100 to <10%, at which point the concentration of oxygenated
hemoglobin
([HbO2])
decreased by ~60%, cytochrome oxidase started to be reduced.
Increases in arterial PO2 under
hyperoxic conditions caused an increase in
[HbO2], whereas further oxidation of cytochrome oxidase was not observed. The dissociation of the responses of hemogloblin and cytochrome oxidase was
also clearly observed after the injection of epinephrine under severely
hypoxic conditions; that is, cytochrome oxidase was reoxidized with
increasing blood pressure, whereas hemoglobin oxygenation was not
changed. These data indicated that oxygen-dependent redox changes in
cytochrome oxidase occur only when oxygen delivery is extremely
impaired. This is consistent with the in vitro data of our previous
study.
mitochondria; oxygen delivery; hypoxia; hemoglobin oxygenation
NEAR-INFRARED SPECTROSCOPY (NIRS), a new noninvasive
technique, measures changes in the hemoglobin (Hb) oxygenation state, blood volume, and the redox state of cytochrome oxidase in
tissue. This technique now finds wide clinical application. Presently, several different types of NIRS instruments are commercially available. However, the specificity and accuracy of the measurement of the redox
state of cytochrome oxidase are still controversial. This is mainly
attributable to the lack of valid absorption spectra for cytochrome
oxidase in the near-infrared region in vivo, although many
investigators have reported different spectra (3, 6, 15). Therefore,
the reported absorption coefficient of copper A, which
accounts for >85% of cytochrome oxidase absorption in the
near-infrared spectrum (1), is ambiguous. This questions the validity
of any algorithms that contain the absorption coefficient of cytochrome
oxidase in simultaneous equations. Thus we have developed a simple and
novel algorithm that does not contain the absorption coefficient of
copper A for cytochrome oxidase measurement. The present method is an
extension of our algorithm for Hb measurement (9), which has been
widely employed in functional mapping studies of human brain activity
(13) as well as in clinical medicine. Preliminary observations in rats
(12) and adult humans (18) by this method have already been published.
In this paper, we describe the details of this method and discuss the
following: 1) the redox behavior of
cytochrome oxidase in the rat brain;
2) the redox state of cytochrome
oxidase under normal physiological conditions; and
3) the significance of the measurement of cytochrome oxidase in living tissue.
Theory.
According to the Beer-Lambert law, the absorbance
(A) of light (at a given wavelength)
as it passes through a nonscattering homogeneous medium is expressed as
where
E is the wavelength-dependent
absorption coefficient of the chromophore in the medium, C is the
concentration of the chromophore, and
L is the distance that light travels
through the medium. The linear dependence of the changes of absorbance at a certain wavelength on concentrations of oxygenated
([HbO2]) or
deoxygenated hemoglobin ([deoxy-Hb]) in tissue
has been confirmed (9, 22). Thus the Beer-Lambert law can be extended
to a light-scattering system like a living tissue, in which
L differs markedly from the physical
optical path because of the strong light scattering (4, 22).
(1)
anaerobic spectrum of the isolated perfused rat brain, absorbance changes attributable to cytochrome oxidase are very small compared with large absorption because of Hb. In
addition, wavelength-dependent absorbance changes are also very small
in this range (unpublished observations). In contrast, the change in OD
in the range longer than 780 nm is attributed to both Hb and oxidized
cytochrome oxidase (9). Thus, when the two measuring wavelengths
(
1 and
2) and one reference
wavelength (
r) are in the
range shorter than 780 nm, the OD difference between
n (the one measuring
wavelength) and
r, A
n
A
r,
can be written as
|
|
(2) |
and
are the difference absorption coefficients of
HbO2 and deoxy-Hb at
n
r,
is the optical path length, and
S
represents absorbance changes attributable to scattering and other
chromophores at
n
r. The optical path length
varies with the scattering coefficient and the geometry of the tissue
but not absorption (8, 22, 23). In our experimental conditions,
however, it becomes constant and is expressed as
l (see
DISCUSSION). Assuming that
S
is a constant, when the condition changes from one to the other, the
change in
A
is simply expressed as
|
(3) |
=
l
and
=
l,
which are defined as the apparent difference absorption coefficients.
When K is the apparent difference
absorption coefficient of either
HbO2 or dexoy-Hb at an arbitrary
wavelength pair
(
0-
r), the ratios of
and
to K are defined as the
proportionality factors at
n
r. The proportionality
factors for HbO2 and deoxy-Hb are
determined experimentally (see below). By the use of the
proportionality factors, Eq. 3 can be
written as
|
(3a) |
are
proportionality factors
(an =
/K,
=
/K).
The change in the absorbance at
3 in the range longer than 780 nm to
r is expressed as
|
(4) |
[cyt ox] is the concentration change in oxidized
cytochrome oxidase, and
a"3 is a
proportionality factor for oxidized cytochrome oxidase, which cannot be
determined experimentally. The changes in
[HbO2] and
[deoxy-Hb] are calculated from Eq. 3a as
|
(5) |
|
(6) |
[cyt ox]
by
|
|
|
(7) |
A730-805 in Fig. 1 is taken as 1, the relative slopes of
A700-805 and
A780-805
are 2 and 0.45, respectively. These relative slope values are
proportionality factors. The linear relationship between absorbance
difference and hematocrit was also obtained with any combinations of
the two wavelengths in the 700- to 900-nm-wavelength region.
NIRS. We employed a four-wavelength method (3 for measuring and 1 for reference, that is, 3 pairs of dual wavelengths) to measure the three-component system ([HbO2], [deoxy-Hb], [cytochrome oxidase]). A portable apparatus was built whereby near-infrared light from a halogen lamp passed through a lens system with a rotating disc containing four interference filters (700-, 730-, 750-, and 805-nm wavelengths; 4-nm half-width) and illuminated the rat's head 5 mm in front of an ear through use of a 4-mm-diameter light guide. Light transmitted through the cranial bone and cerebral tissue was guided through another light guide to a photomultiplier tube. The changes in light intensity at each wavelength were measured by the use of a sample-and-hold circuit and recorded after logarithmic transformation. The changes in [HbO2], [deoxy-Hb], and [cytochrome oxidase] were calculated by the following numerical formulas derived from Eqs. 5-7
|
|
(8) |
|
Experiments were repeated with five to seven rats in each experiment, and results were identical within experimental error. Thus data in Figs. 1, 2, 3, 4, 5 are those of representative cases.
Changes in cerebral oxygenation caused by hypoxic hypoxia. Figure 2A shows changes in cerebral oxygenation, cerebral blood volume (CBV), and BP during stepwise decreases in FIO2 from 100 to 0%. Each EEG (samples 1-4) in Fig. 2B was measured at the point marked on the trace of the relative percentage of [cytochrome oxidase]. When FIO2 was decreased from 100 to 10%, [HbO2] decreased and [deoxy-Hb] increased reciprocally, whereas the redox state of cytochrome oxidase was not changed. Lowering FIO2 from 20 to 15% caused desynchronization on the EEG (sample 2 in Fig. 2B). When FIO2 was decreased to 10%, BP started to fall and cytochrome oxidase started to be reduced. Decreasing FIO2 further, when [cytochrome oxidase] was decreased to between 35 and 40%, resulted in the appearance of high-voltage slow waves on the EEG (sample 3 in Fig. 2B). Flattening of the EEG occurred with a delay of a few seconds after cytochrome oxidase was fully reduced under anoxic conditions (sample 4 in Fig. 2B). The behavior of absorbance change at 805 nm [isosbestic point of HbO2 and deoxy-Hb (11)] was similar to that of the change in the concentration of total hemoglobin ([HbT]), a numerical summation of [HbO2] and [deoxy-Hb]. Both changes in [HbT] and the absorbance at 805 nm are thought to reflect changes in CBV within the optical field. Under severely hypoxic conditions in which FIO2 was decreased from 6 to 0%, however, they showed different behavior: whereas [HbT] did not show any further changes, the absorbance at 805 nm decreased. This decrease in absorbance might have been due to overlap of the reduction of cytochrome oxidase. This meant that, under the condition in which cytochrome oxidase was reduced, the absorbance change at 805 nm could not be used as an indicator of changes in blood volume. Figure 3 shows the relative oxidation state of cytochrome oxidase with respect to the relative oxygenation state of Hb obtained from six independent experiments similar to those shown in Fig. 2A. The redox state of cytochrome oxidase was unchanged and independent of changes in [HbO2], until [HbO2] decreased to ~40% in hypoxic hypoxia. In the range lower than this level of [HbO2], then, [cytochrome oxidase] was decreased almost linearly with decreases in [HbO2]. When [cytochrome oxidase] was decreased to <40%, a condition in which high-voltage slow waves appeared on the EEG, [HbO2] was decreased to between 10 and 15%. Effects of increases in CBF on cerebral oxygenation. We examined effects of increases in CBF induced by hypercapnia under hyperoxic conditions and intravenous injection of epinephrine under hypoxic conditions. Stepwise increases in FICO2 were accompanied by decreases in FIO2 to 88% at most, at which point arterial PO2 (PaO2) and PaCO2 were 353 and 117 Torr, respectively. Increases in FICO2 caused increases in both [HbT] and the absorbance at 805 nm (data not shown), which resulted in increases in [HbO2] to a maximum of 20% (Fig. 4). In contrast to [HbO2], no increase of [cytochrome oxidase] was observed. When FIO2 was 15%, [HbO2] was decreased to ~65%, but [cytochrome oxidase] was not yet decreased. In these circumstances, intravenous injection of epinephrine (1 µg/100 g body wt) caused an immediate elevation of BP, and [HbO2] increased transiently, whereas further oxidation of cytochrome oxidase was not observed (Fig. 5). When FIO2 was 4%, under which condition [HbO2] decreased to ~10% and [cytochrome oxidase] decreased to ~30%, administration of the same amount of epinephrine also caused an increase in BP. The degree of an increase in BP was similar to that observed when FIO2 was 15%. Unlike the case with an FIO2 of 15%, however, an increase in [HbO2] was not observed, whereas cytochrome oxidase was markedly oxidized. [HbT] and [deoxy-Hb] increased slightly. This meant that delivery of oxygen from capillaries to mitochondria increased, which was accomplished by increased flow velocity. This result also meant that the volume of the small venous vessels changed in passive response to the flow change.
8 M. The
P50 of Hb is 4.2 × 10
5 M. Judging from this
calibration, our results are acceptable.
There are several possible sources of error that interfere with the
accurate measurement of the redox state of cytochrome oxidase. However,
our method eliminates the most problematic source, that is, inaccuracy
of the spectrum of cytochrome oxidase. In addition, classic
dual-wavelength analysis provides adequate compensation for the
light-scattering change of tissue itself and for instability of the
photomultiplier or light source (20). One important assumption of our
algorithm is that the redox change of cytochrome oxidase gives no
absorbance changes in the region of 700-780 nm, as reported for
the anoxic
aerobic spectrum of the blood-fluorocarbon-exchanged rat head (9). This has been questioned by the spectra obtained from
Hb-free rats by Miyake et al. (21) and Wray et al. (27). Recently, we
have also observed the small absorbance change in the region shorter
than 780 nm in the aerobic
anaerobic
spectrum of the isolated perfused rat brain. However, in
the 700- to 750-nm-wavelength region, absorbance changes attributed to
cytochrome oxidase were very small compared with large absorption due
to Hb. In addition, wavelength-dependent absorbance changes were also
very small in this region, even in the difference spectrum reported by
others. Because of dual-wavelength analysis, such a small contribution may not cause significant errors. Thus our assumption is valid as long
as the region of 700-750 nm is employed for measuring the Hb
oxygenation state.
It is well known that scattering intensity is dependent on wavelength.
Because a maximal difference between
n and
r used here is 55 nm, however,
a difference in scattering intensity between two wavelengths is small.
The principle of the dual-wavelength method, thus, also enables us to
assume that the optical path length is constant. Under hypoxic
conditions, several changes occur in cells, such as the collapse of
membrane potentials, which can produce changes in light-scattering
characteristics. We have observed that marked changes in scattering
intensity suddenly occurred when cytochrome oxidase was almost fully
reduced under hypoxic conditions in the perfused rat head (unpublished
observations). This has been also confirmed by direct measurement of
the reduced-scattering coefficient of the piglet brain (29). These data
indicate that scattering changes are small and can be eliminated by
dual-wavelength analysis, except those under severely hypoxic
conditions.
It must be noted here that the coefficients in Eq. 8, which were determined experimentally in living
tissue of the rat head, contain instrumentation factors such as the
half-width of the optical filters used. When a new instrument is
assembled, we therefore have to reestimate these factors. This
procedure is inconvenient. However, we have recently found that we can
obtain identical proportionality factors in conditions in vitro by the
use of red blood cell suspension (unpublished observations). Thus the
in vitro data can be used in Eq. 8
when instrumentation factors change.
Redox state of cytochrome oxidase in normal physiological
conditions.
A general conclusion that has emerged from recent studies (2, 7, 24,
26) is that oxygen-dependent redox changes of cytochrome oxidase seem
to occur only when oxygen delivery is extremely compromised. Our
present data support this conclusion. However, the issue of whether or
not cytochrome oxidase is partially reduced in normoxia remains to be
solved. Edwards et al. (5), who reported that there was no relationship
between cerebral [cytochrome oxidase] and
SaO2 within the range of 85-99%,
whereas increases in PaCO2 from 4.3 to
9.6 kPa were accompanied by those in both [cytochrome
oxidase] and
[HbT] in
newborn preterm human infants, have argued that cytochrome oxidase
might be partially reduced. In their study, the oxidation of cytochrome
oxidase after increasing PaCO2 was
explained by the assumption that the copper A varied with the
mitochondrial energy level in addition to the hemodynamic
characteristics of the human neonatal brain. In this study, however,
neither increases in PaCO2 under
hyperoxic conditions (Fig. 4) nor intravenous injection of epinephrine
under mildly hypoxic conditions (Fig. 5) caused further oxidation of
cytochrome oxidase, whereas
[HbO2] was increased.
This discrepancy in the effect of hemodynamic changes on the redox
state of cytochrome oxidase might be due to the difference in species
and/or the difference between the adult and the newborn brain.
However, our previous in vitro mitochondrial studies demonstrated that
oxygen dependence of the redox state of copper A is independent of the
mitochondrial energy state and respiratory rate (11). Thus, as for in
vitro mitochondria at least, it is unlikely that the partial reduction of copper A in cytochrome oxidase occurs in normoxia by the mechanism Edwards et al. proposed (i.e., energy-dependent redox change of copper
A).
Significance of measurement of redox state of cytochrome oxidase.
Recently, several investigators proposed that
[HbO2] may be the best
indicator of impending brain hypoxia, whereas the reduction of
cytochrome oxidase may be a prognosticator of irreversible brain damage
because it occurs only under extreme hypoxia (2, 7). At the moment,
however, NIRS does not provide quantitative information, although great
efforts have been made toward quantitation. Thus the degree of cerebral
hypoxia cannot be judged by near-infrared measurement of Hb oxygenation
alone. When Hb oxygenation decreases in sick patients requiring
intensive care, for example, we cannot decide whether we should treat
them immediately without other monitoring systems. By contrast, the
reduction of cytochrome oxidase preceded the appearance of high-voltage
slow waves on the EEG (Fig. 2B). In
hypoxic hypoxia, the appearance of these waves on the EEG indicates a
decline in cerebral function. In addition, studies on the correlation
of the cytochrome oxidase signal with the brain-energy states of
piglets (26) and dogs (25) have shown that the reduction of cytochrome
oxidase is highly correlated with a decreased brain-energy state. These
data suggest that the brain works as long as cytochrome oxidase is
maintained in the fully oxidized state. It therefore appears that the
start of cytochrome oxidase reduction can be used as an alarm,
notifying that the brain condition is metabolically and functionally
critical, even though absolute values are lacking.
Before the advent of NIRS, we evaluated tissue oxygenation from several
indirect variables such as PaO2. These
methods, however, sometimes do not reflect tissue oxygenation
correctly. As is seen in Fig. 5, intravenous injection of epinephrine
was effective for increasing oxygen delivery to the brain tissue under
severely hypoxic conditions. This could be confirmed by measuring the
redox state of cytochrome oxidase but not by Hb. Thus direct
measurement of the tissue oxygen concentration is essential for
evaluating tissue oxygen sufficiency. Among the various clinical
monitoring systems, only near-infrared measurement of cytochrome
oxidase can meet this demand. We are now investigating clinical
applications of our method to examine the value of NIRS.
Address for reprint requests: Y. Hoshi, Biophysics Group, Research Institute for Electronic Science, Hokkaido Univ., Sapporo 060, Japan.
Received 9 December 1996; accepted in final form 21 July 1997.
| 1. | Beinert, H., R. W. Shaw, R. E. Hansen, and C. R. Hartzell. Studies on the origin of near infrared (800-900 nm) absorption of cytochrome-c oxidase. Biochim. Biophys. Acta 591: 458-470, 1980[Medline]. |
| 2. | Cooper, C. E., S. J. Matcher, J. S. Wyatt, M. Cope, G. C. Brown, E. M. Nemoto, and D. T. Delpy. Near-infrared spectroscopy of the brain: relevance to cytochrome oxidase bioenergetics. Biochem. Soc. Trans. 22: 974-980, 1994[Medline]. |
| 3. | Cope, M., D. T. Delpy, S. Wray, J. S. Wyatt, and E. O. R. Raynolds. A CCD spectrophotometer to quantitate the concentration of water at 975 nm. Adv. Exp. Med. Biol. 248: 33-46, 1989[Medline]. |
| 4. | Delpy, D. T., M. Cope, P. van der Zee, S. Arridge, S. Wray, and J. S. Wyatt. Estimation of optical pathlength through tissue by direct time of flight measurement. Phys. Med. Biol. 33: 1433-1442, 1998. |
| 5. |
Edwards, A. D.,
G. C. Brown,
M. Cope,
J. S. Wyatt,
D. C. McCormick,
S. C. Roth,
D. T. Delpy,
and
E. O. R. Reynolds.
Quantification of concentration changes in neonatal human cerebral oxidized cytochrome oxidase.
J. Appl. Physiol.
71:
1907-1913,
1991 |
| 6. |
Ferrari, M.,
D. F. Hanley,
D. A. Wilson,
and
R. J. Traystman.
Redox changes in cat brain cytochrome-c oxidase after blood-fluorocarbon exchange.
Am. J. Physiol.
258 ((Heart Circ. Physiol. 27):
H1706-H1713,
1990 |
| 7. |
Ferrari, M.,
M. A. Williams,
D. A. Wilson,
N. V. Thakor,
R. J. Traystman,
and
D. F. Hanley.
Cat brain cytochrome-c oxidase redox changes induced by hypoxia after blood-fluorocarbon exchange transfusion.
Am. J. Physiol.
269 ((Heart Circ. Physiol. 38):
H417-H424,
1995 |
| 8. | Furutsu, K., and Y. Yamada. Diffusion approximation for a dissipative random medium and the applications. Physiol. Rev. E50: 3634-3640, 1994. |
| 9. |
Hazeki, O.,
and
T. Tamura.
Quantitative analysis of hemoglobin oxygenation state of rat brain in situ by near-infrared spectrophotometry.
J. Appl. Physiol.
64:
796-802,
1988 |
| 10. | Hempel, F. G., K. Kariman, and H. A. Saltzman. Redox transitions in mitochondria of cat cerebral cortex with seizure and hemorrhagic hypotension. Am. J. Physiol. 238 ((Heart Circ. Physiol. 7): H249-H256, 1980. |
| 11. |
Hoshi, Y.,
O. Hazeki,
and
M. Tamura.
Oxygen dependence of redox state of copper in cytochrome oxidase in vitro.
J. Appl. Physiol.
74:
1622-1627,
1993 |
| 12. | Hoshi, Y., and M. Tamura. Dynamic changes in cerebral oxygenation in chemically induced seizures in rat: study by near-infrared spectrophotometry. Brain Res. 603: 215-221, 1993[Medline]. |
| 13. |
Hoshi, Y.,
and
M. Tamura.
Dynamic multichannel near-infrared optical imaging of human brain activity.
J. Appl. Physiol.
75:
1842-1846,
1993 |
| 14. |
Inagaki, M.,
and
M. Tamura.
Preparation and optical characteristics of hemoglobin-free isolated perfused rat head in situ.
J. Biochem. (Tokyo)
113:
650-657,
1993 |
| 15. | Jöbsis, F. F. Oxidative metabolic effects of cerebral hypoxia. Adv. Neurol. 26: 299-318, 1979[Medline]. |
| 16. |
Jöbsis, F. F.,
J. H. Keizer,
J. C. LaManna,
and
M. Rosenthal.
Reflectance spectrophotometry of cytochrome aa3 in vivo.
J. Appl. Physiol.
43:
858-872,
1977 |
| 17. | Kakihana, Y., and M. Tamura. Near infrared optical monitoring of cardiac oxygen sufficiency through thoracic wall without open chest surgery. Soc. Photo-Optical Instrumentation Eng. 1431: 314-320, 1991. |
| 18. | Kuroda, S., K. Houkin, H. Abe, Y. Hoshi, and M. Tamura. Near-infrared monitoring of cerebral oxygenation state during carotid endoarterectomy. Surg. Neurol. 45: 450-458, 1996[Medline]. |
| 19. | Matsunaga, A., Y. Nomura, and M. Tamura. The energy dependent redox responses of heme and copper in cytochrome oxidase in rat brain in situ. Adv. Exp. Med. Biol. 388: 305-310, 1996[Medline]. |
| 20. | Millikan, G. A. Experiments on muscle hemoglobin in vivo; the instantaneous measurement of muscle metabolism. Proc. Roy. Soc. B. 123: 218-243, 1937. |
| 21. | Miyake, H., S. Nioka, D. S. Smith, and B. Chance. The detection of cytochrome oxidase heme iron and copper absorption in the blood-perfused and blood-free brain in normoxia and hypoxia. Anal. Biochem. 192: 149-155, 1991[Medline]. |
| 22. |
Nomura, Y.,
and
M. Tamura.
Quantitative analysis of the hemoglobin oxygenation state of rat brain in vivo by picosecond time-resolved spectrometry.
J. Biochem. (Tokyo)
109:
455-461,
1991 |
| 23. | Oda, M., Y. Yamashita, G. Nishimura, and M. Tamura. A simple and novel algorithm for time-resolved multiwavelength oximetry. Phys. Med. Biol. 41: 551-562, 1996[Medline]. |
| 24. | Sylvia, A. L., and C. A. Piantadosi. O2 dependence of in vivo brain cytochrome redox responses and energy metabolism in bloodless rats. J. Cereb. Blood Flow Metab. 8: 163-172, 1988[Medline]. |
| 25. | Tamura, M., O. Hazeki, S. Nioka, B. Chance, and D. S. Smith. The simultaneous measurements of tissue oxygen concentration and energy state by near-infared and nuclear magnetic resonance spectroscopy. In: Chemoreceptors and Reflexes in Breathing, edited by S. Lahiri. New York: Oxford Univ. Press, 1988, p. 91-93. |
| 26. | Tsuji, M., H. Naruse, J. Volpe, and D. Hotzman. Reduction of cytochrome aa3 measured by near-infrared spectroscopy predicts cerebral energy loss in hypoxic piglets. Pediatr. Res. 37: 253-259, 1995[Medline]. |
| 27. | Wray, S., M. Cope, D. T. Delpy, J. S. Wyatt, and E. O. R. Reynolds. Characterization of the near-infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation. Biochim. Biophys. Acta 933: 184-192, 1988[Medline]. |
| 28. | Wyatt, J. S., M. Cope, D. T. Delpy, S. Wray, and E. O. R. Reynolds. Quantification of cerebral oxygenation and haemodynamics in sick newborn infants by near infrared spectrophotometry. Lancet 2: 1063-1066, 1986[Medline]. |
| 29. | Yamashita, Y., M. Oda, H. Naruse, and M. Tamura. In vivo measurement of reduced scattering and absorption coefficients of living tissue using time-resolved spectroscopy. In: OSA Trends in Optics and Photonics on Advances in Optical Imaging and Photon Migration, edited by R. R. Alfano, and J. G. Fujimoto. Washington, DC: Optical Society of America, 1996, vol. 2, p. 387-390. |
This article has been cited by other articles:
![]() |
E. A. L Gallagher, J. P Newman, L. R Green, and M. A Hanson The effect of low protein diet in pregnancy on the development of brain metabolism in rat offspring J. Physiol., October 15, 2005; 568(2): 553 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shah, C.-H. Tung, C.-H. Chang, E. Slootweg, T. O'Loughlin, X. O. Breakefield, and R. Weissleder In Vivo Imaging of HIV Protease Activity in Amplicon Vector-transduced Gliomas Cancer Res., January 1, 2004; 64(1): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nagdyman, T. P. K. Fleck, P. Ewert, H. Abdul-Khaliq, M. Redlin, and P. E. Lange Cerebral oxygenation measured by near-infrared spectroscopy during circulatory arrest and cardiopulmonary resuscitation Br. J. Anaesth., September 1, 2003; 91(3): 438 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Scheufler, H.-J. Rohrborn, and J. Zentner Does Tissue Oxygen-Tension Reliably Reflect Cerebral Oxygen Delivery and Consumption? Anesth. Analg., October 1, 2002; 95(4): 1042 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kakihana, A. Matsunaga, K. Tobo, S. Isowaki, M. Kawakami, I. Tsuneyoshi, Y. Kanmura, and M. Tamura Redox behavior of cytochrome oxidase and neurological prognosis in 66 patients who underwent thoracic aortic surgery Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 434 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hoshi, N. Kobayashi, and M. Tamura Interpretation of near-infrared spectroscopy signals: a study with a newly developed perfused rat brain model J Appl Physiol, May 1, 2001; 90(5): 1657 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Springett, J. Newman, M. Cope, and D. T. Delpy Oxygen dependency and precision of cytochrome oxidase signal from full spectral NIRS of the piglet brain Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2202 - H2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Tung, U. Mahmood, S. Bredow, and R. Weissleder In Vivo Imaging of Proteolytic Enzyme Activity Using a Novel Molecular Reporter Cancer Res., September 1, 2000; 60(17): 4953 - 4958. [Abstract] [Full Text] |
||||
![]() |
J. P. Newman, D. M. Peebles, S. R. G. Harding, R. Springett, and M. A. Hanson Hemodynamic and metabolic responses to moderate asphyxia in brain and skeletal muscle of late-gestation fetal sheep J Appl Physiol, January 1, 2000; 88(1): 82 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. SHIBATA, H. OHDAN, T. NORIYUKI, S. YOSHIOKA, T. ASAHARA, and K. DOHI Novel Assessment of Acute Lung Injury by In Vivo Near-Infrared Spectroscopy Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 317 - 323. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |